Strontium-89: Clinical Trials

3 trials of Strontium-89, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow Strontium-89: new trials by email Literature Review of Strontium-89 trials Research Report on Strontium-89

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Doxorubicin hydrochloride, Goserelin acetate, Leuprolide acetate - Metastatic Cancer, Prostate Cancer
Phase 2CompletedM.D. Anderson Cancer Center802004-07-012016-11-10
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate Cancer
strontium-89, cisplatin - Hormone Refractory Prostate Cancer, Bone Metastases
Phase 2CompletedAlberta Health services582003-08-012012-01-19
Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
Celecoxib, Doxorubicin Hydrochloride, Strontium chloride Sr 89 - Metastatic Cancer, Prostate Cancer
Phase 2TerminatedM.D. Anderson Cancer Center142002-02-012018-10-31

Conditions studied

Prostatic Neoplasms (3)  ·  Neoplasm Metastasis (2)

Sponsors

M.D. Anderson Cancer Center (2)  ·  Alberta Health services (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Shi-Ming Tu, MD (2)  ·  Bernie Eigl, MD (1)  ·  Jackson Wu (1)

NIH funding

P30CA016672 (1), P50CA090270 (1), U10CA045809 (1)